Nektar Therapeutics (NKTR) Tops Q2 EPS by 9c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $75.92 --0%
Financial Fact:
Other income (expense), net: 332K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Other income (expense), net: 332K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q2 EPS of ($0.85), $0.09 better than the analyst estimate of ($0.94). Revenue for the quarter came in at $21.6 million versus the consensus estimate of $22.75 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
